Transforming growth factor β1, matrix metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation Glaucoma/Syndrome;Transformišući faktor rasta β1, matriks metaloproteinaza-2 i njen tkivni inhibitor kod bolesnika sa pseudoeksfolijativnim Sindromom/Glaukomom

Vojnosanitetski Pregled

Volumn 69, Issue 3, 2012, Pages 231-236

  Djordjević Jocić, Jasmina ^a   Zlatanović, Gordana ^a   Veselinović, Dragan ^a   Jovanović, Predrag ^a   Djordjević, Vidosava ^a   Zvezdanović, Lilika ^a   Stanković Babić, Gordana ^a   Vujanović, Milena ^a   Cekić, Sonja ^a   Zenkel, Matthias ^b   Schlotzer Schrehardt, Ursula ^b  

^a CLINICAL CENTER NIS   (Serbia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Exfoliation syndrome; Matrix metaloproteinase 2; Tissue inhibitor of metaloproteinase 2; Transforming growth factor beta 1

Indexed keywords

GELATINASE A; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ANTERIOR EYE CHAMBER ANGLE; AQUEOUS HUMOR; ARTICLE; CATARACT; CONTROLLED STUDY; CORRELATION ANALYSIS; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PHACOEMULSIFICATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOEXFOLIATION;

AGED; AQUEOUS HUMOR; CATARACT; EXFOLIATION SYNDROME; GLAUCOMA, OPEN-ANGLE; HUMANS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84857763040     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1203231D     Document Type: Article

References (18)

1. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res 2003; 22(3): 253-75.
2. Ritch R. Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma. J Glaucoma 1994; 3(2): 176-7.
3. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001; 45(4): 265-315.
4. Schlötzer-Schrehardt U, Küchle M, Jünemann A, Naumann GO. Relevance of the pseudoexfoliation syndrome for the glaucomas. Ophthalmologe 2002; 99(9): 683-90. (German)
5. Topouzis F, Harris A, Wilson MR, Koskosas A, Founti P, Yu F, et al. Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study. Am J Ophthalmol 2009; 148(4): 606-13.e1.
6. Lütjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog Retin Eye Res 1999; 18(1): 91-119.
7. Grierson I, Pfeiffer N, Cracknell KP, Appleton P. Histology and fine structure of the iris and outflow system following latanoprost therapy. Surv Ophthalmol 2002; 47 Suppl 1: S176-84.
8. Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 2005; 24(5): 612-37.
9. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res 1998; 17(3): 276-85.
10. Chintala SK, Wang N, Diskin S, Mattox C, Kagemann L, Fini ME, et al. Matrix metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs. Exp Eye Res 2005; 81(4): 429-36.
11. Yüksel N, Karabas VL, Arslan A, Demirci A, Caglar Y. Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 2001; 108(6): 1043-9.
12. Esaki K, Ito K, Matsunaga K, Sugimoto K, Sasoh M, Uji Y. Anterior chamber structural change in postural variation in pseudoexfoliation syndrome. Nihon Ganka Gakkai Zasshi 2001; 105(8): 524-9. (Japanese)
13. Koliakos GG, Schlötzer-Schrehardt U, Konstas AG, Bufidis T, Georgiadis N, Dimitriadou A. Transforming and insulin-like growth factors in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2001; 239(7): 482-7.
14. Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AG, Naumann GO. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003; 44(3): 1117-25.
15. Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141(5): 921-37.
16. Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Naumann GO. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 2001; 73(6): 765-80.
17. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92(8): 827-39.
18. Määttä M, Tervahartiala T, Harju M, Airaksinen J, Autio- Harmainen H, Sorsa T. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma 2005; 14(1): 64-9.